Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
C3.ai, Inc. stock logo
AI
C3.ai
$24.44
-1.3%
$26.38
$19.03
$48.87
$2.98B1.746.90 million shs3.53 million shs
Clarivate Plc stock logo
CCC
Clarivate
$0.02
$29.06
$15.00
$33.55
$12.12M0.531.24 million shs19,871 shs
Clarivate Plc stock logo
CLVT
Clarivate
$6.16
-11.4%
$7.16
$6.07
$10.03
$4.12B1.244.11 million shs7.06 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
C3.ai, Inc. stock logo
AI
C3.ai
-0.04%+9.99%-1.55%-4.10%+28.81%
Clarivate Plc stock logo
CCC
Clarivate
0.00%0.00%0.00%0.00%0.00%
Clarivate Plc stock logo
CLVT
Clarivate
-1.42%+2.89%-5.70%-24.70%-8.19%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
C3.ai, Inc. stock logo
AI
C3.ai
2.9545 of 5 stars
3.11.00.03.21.11.70.6
Clarivate Plc stock logo
CCC
Clarivate
N/AN/AN/AN/AN/AN/AN/AN/A
Clarivate Plc stock logo
CLVT
Clarivate
3.0154 of 5 stars
3.01.00.00.03.73.31.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
C3.ai, Inc. stock logo
AI
C3.ai
2.22
Hold$31.5028.89% Upside
Clarivate Plc stock logo
CCC
Clarivate
N/AN/AN/AN/A
Clarivate Plc stock logo
CLVT
Clarivate
2.00
Hold$8.0029.87% Upside

Current Analyst Ratings

Latest AI, BC8, CLVT, SCT, and CCC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/4/2024
C3.ai, Inc. stock logo
AI
C3.ai
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$27.00 ➝ $33.00
2/29/2024
C3.ai, Inc. stock logo
AI
C3.ai
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$42.00 ➝ $35.00
2/29/2024
C3.ai, Inc. stock logo
AI
C3.ai
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$18.00 ➝ $20.00
2/29/2024
C3.ai, Inc. stock logo
AI
C3.ai
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$27.00 ➝ $31.00
2/28/2024
Clarivate Plc stock logo
CLVT
Clarivate
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$9.00 ➝ $8.00
2/28/2024
Clarivate Plc stock logo
CLVT
Clarivate
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$7.00 ➝ $6.00
2/28/2024
Clarivate Plc stock logo
CLVT
Clarivate
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$10.00 ➝ $8.00
2/28/2024
Clarivate Plc stock logo
CLVT
Clarivate
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$11.00 ➝ $10.00
(Data available from 5/8/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
C3.ai, Inc. stock logo
AI
C3.ai
$266.80M11.18N/AN/A$8.29 per share2.95
Clarivate Plc stock logo
CCC
Clarivate
$974.34M0.01$0.00 per share29.97$4.43 per share0.00
Clarivate Plc stock logo
CLVT
Clarivate
$2.63B1.57$1.64 per share3.76$6.93 per share0.89

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
C3.ai, Inc. stock logo
AI
C3.ai
-$268.84M-$2.33N/AN/AN/A-95.21%-29.60%-25.12%5/29/2024 (Confirmed)
Clarivate Plc stock logo
CCC
Clarivate
-$210.98M$0.35N/A0.03N/A-18.75%7.92%3.39%N/A
Clarivate Plc stock logo
CLVT
Clarivate
-$911.20M-$1.48N/A9.191.41-34.66%9.95%3.89%5/8/2024 (Confirmed)

Latest AI, BC8, CLVT, SCT, and CCC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/29/2024N/A
C3.ai, Inc. stock logo
AI
C3.ai
-$0.31N/A+$0.31N/AN/AN/A  
5/8/2024N/A
Clarivate Plc stock logo
CLVT
Clarivate
$0.1370$0.14+$0.0030N/A$614.85 million$621.20 million    
2/28/2024Q3 2024
C3.ai, Inc. stock logo
AI
C3.ai
-$0.73-$0.60+$0.13-$0.60$75.92 million$78.40 million
2/27/202412/31/2023
Clarivate Plc stock logo
CLVT
Clarivate
$0.21$0.21N/A$1.72$687.80 million$683.70 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
C3.ai, Inc. stock logo
AI
C3.ai
N/AN/AN/AN/AN/A
Clarivate Plc stock logo
CCC
Clarivate
N/AN/AN/AN/AN/A
Clarivate Plc stock logo
CLVT
Clarivate
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
C3.ai, Inc. stock logo
AI
C3.ai
N/A
8.48
8.48
Clarivate Plc stock logo
CCC
Clarivate
0.81
1.42
1.42
Clarivate Plc stock logo
CLVT
Clarivate
1.03
0.91
0.91

Ownership

Institutional Ownership

CompanyInstitutional Ownership
C3.ai, Inc. stock logo
AI
C3.ai
38.96%
Clarivate Plc stock logo
CCC
Clarivate
42.83%
Clarivate Plc stock logo
CLVT
Clarivate
85.72%

Insider Ownership

CompanyInsider Ownership
C3.ai, Inc. stock logo
AI
C3.ai
34.00%
Clarivate Plc stock logo
CCC
Clarivate
2.32%
Clarivate Plc stock logo
CLVT
Clarivate
23.14%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
C3.ai, Inc. stock logo
AI
C3.ai
914122.05 million80.55 millionOptionable
Clarivate Plc stock logo
CCC
Clarivate
4,090605.96 millionN/ANot Optionable
Clarivate Plc stock logo
CLVT
Clarivate
12,000668.14 million513.54 millionOptionable

AI, BC8, CLVT, SCT, and CCC Headlines

SourceHeadline
Clarivate (NYSE:CLVT) Trading Down 8.3%Clarivate (NYSE:CLVT) Trading Down 8.3%
marketbeat.com - May 8 at 7:07 PM
CLVT Stock Earnings: Clarivate Meets EPS, Beats Revenue for Q1 2024CLVT Stock Earnings: Clarivate Meets EPS, Beats Revenue for Q1 2024
msn.com - May 8 at 6:12 PM
Clarivate (NYSE:CLVT) Releases FY24 Earnings GuidanceClarivate (NYSE:CLVT) Releases FY24 Earnings Guidance
marketbeat.com - May 8 at 2:29 PM
Compared to Estimates, Clarivate (CLVT) Q1 Earnings: A Look at Key MetricsCompared to Estimates, Clarivate (CLVT) Q1 Earnings: A Look at Key Metrics
zacks.com - May 8 at 10:36 AM
Clarivate Plc: Clarivate Reports First Quarter 2024 ResultsClarivate Plc: Clarivate Reports First Quarter 2024 Results
finanznachrichten.de - May 8 at 8:55 AM
Clarivate Analytics Non-GAAP EPS of $0.14 in-line, revenue of $621.2M beats by $6.35MClarivate Analytics Non-GAAP EPS of $0.14 in-line, revenue of $621.2M beats by $6.35M
seekingalpha.com - May 8 at 8:55 AM
Clarivate Posts Loss In Q1; Reaffirms FY24 OutlookClarivate Posts Loss In Q1; Reaffirms FY24 Outlook
markets.businessinsider.com - May 8 at 8:55 AM
Clarivate PLC (CLVT) Q1 2024 Earnings: Mixed Results Amidst Operational ChallengesClarivate PLC (CLVT) Q1 2024 Earnings: Mixed Results Amidst Operational Challenges
finance.yahoo.com - May 8 at 8:55 AM
Shareholders in Clarivate (NYSE:CLVT) are in the red if they invested three years agoShareholders in Clarivate (NYSE:CLVT) are in the red if they invested three years ago
finance.yahoo.com - May 8 at 8:55 AM
Clarivate PLC (CLVT) Q1 Earnings Meet EstimatesClarivate PLC (CLVT) Q1 Earnings Meet Estimates
zacks.com - May 8 at 8:15 AM
Clarivate Reports First Quarter 2024 ResultsClarivate Reports First Quarter 2024 Results
prnewswire.com - May 8 at 6:00 AM
Clarivate Plc: Clarivate Introduces Epidemiology Intelligence for Precision Patient Population AnalysisClarivate Plc: Clarivate Introduces Epidemiology Intelligence for Precision Patient Population Analysis
finanznachrichten.de - May 7 at 4:40 AM
Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population AnalysisClarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis
prnewswire.com - May 7 at 3:00 AM
Analyzing Clarivate (NYSE:CLVT) and DATATRAK International (OTCMKTS:DTRK)Analyzing Clarivate (NYSE:CLVT) and DATATRAK International (OTCMKTS:DTRK)
americanbankingnews.com - May 5 at 1:30 AM
Raymond James & Associates Buys 297,286 Shares of Clarivate Plc (NYSE:CLVT)Raymond James & Associates Buys 297,286 Shares of Clarivate Plc (NYSE:CLVT)
marketbeat.com - May 4 at 9:25 PM
Exor N.V. Purchases 33,256,346 Shares of Clarivate Plc (NYSE:CLVT)Exor N.V. Purchases 33,256,346 Shares of Clarivate Plc (NYSE:CLVT)
marketbeat.com - May 2 at 7:26 PM
Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory SuccessClarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success
prnewswire.com - May 2 at 3:00 AM
Clarivate Declares Dividend on Mandatory Convertible Preferred SharesClarivate Declares Dividend on Mandatory Convertible Preferred Shares
prnewswire.com - May 1 at 4:05 PM
Clarivate PLC (CLVT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Clarivate PLC (CLVT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
zacks.com - May 1 at 11:05 AM
Clarivate Plc (NYSE:CLVT) Shares Sold by Zurcher Kantonalbank Zurich CantonalbankClarivate Plc (NYSE:CLVT) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank
marketbeat.com - May 1 at 4:52 AM
Clarivate (CLVT) Scheduled to Post Quarterly Earnings on WednesdayClarivate (CLVT) Scheduled to Post Quarterly Earnings on Wednesday
americanbankingnews.com - May 1 at 4:24 AM
BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special ReportBioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report
prnewswire.com - April 30 at 3:00 AM
Clarivate Announces Winners of the South Asia Innovation Awards 2024Clarivate Announces Winners of the South Asia Innovation Awards 2024
theprint.in - April 26 at 1:38 AM
Clarivate joins United Nations SDG Publishers CompactClarivate joins United Nations SDG Publishers Compact
prnewswire.com - April 24 at 3:00 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

C3.ai logo

C3.ai

NYSE:AI
C3.ai, Inc. operates as an enterprise artificial intelligence (AI) software company in North America, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides C3 AI platform, an application development and runtime environment that enables customers to design, develop, and deploy enterprise AI applications; C3 AI Ex Machina for analysis-ready data; C3 AI CRM, an industry specific customer relationship management solution; and C3 Generative AI Product Suite that enables to locate, retrieve, and present information. It also offers C3 AI applications, including C3 AI Inventory Optimization, a solution to optimize raw material, in-process, and finished goods inventory levels; C3 AI Supply Network Risk, which identifies emerging inbound and outbound risks across the network; C3 AI Sustainability Suite, which helps to decrease greenhouse gas emission; C3 AI Production Schedule Optimization, a solution for scheduling production; C3 AI Financial Services Suite, which helps to minimize compliance risks; and C3 AI Energy Management solution. In addition, it offers integrated turnkey enterprise AI applications for oil and gas, chemicals, utilities, manufacturing, financial services, defense, intelligence, aerospace, healthcare, and telecommunications market. It has strategic partnerships with Baker Hughes in the areas of oil and gas market; Booz Allen to provide solutions to government, defense, and intelligence sectors; Raytheon; and AWS, Google, and Microsoft. The company was formerly known as C3 IoT, Inc. and changed its name to C3.ai, Inc. in June 2019. C3.ai, Inc. was incorporated in 2009 and is headquartered in Redwood City, California.
Clarivate logo

Clarivate

NYSE:CCC
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
Clarivate logo

Clarivate

NYSE:CLVT
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.